IDCMR2025

Abstract Submission

SUBMISSION INFORMATION

TIMELINE FOR ABSTRACT SUBMISSION
Date : 31 July 2025	Draft Abstract deadline
Date : 15 August 2025	Review Abstract Submission
Date : 31 August 2025	Resubmit Abstract Submission
Date : 2 September 2025	Accept and confirm
Date : 15 September 2025	Preparation for E-book
Date : 1 October 2025	Print or design E-book
Date : 15 October or 16 October 2025	Rehearse and refine Poster Installation

SUBMISSION GUIDELINES/FORMATTING

Abstract Rules and Submission Guidelines
On behalf of Prince of Songkla University Faculty of Dentistry and the IDCMR Secretariat Office welcome the submission of original contributions for oral and poster presentations at the IDCMR congress.

DEADLINE: JULY 15, 2025
Abstracts received after this date will not be considered.

INSTRUCTIONS TO AUTHORS
Carefully read the guidelines below before submitting an abstract. Acknowledgement of the receipt of your submission will be sent to the corresponding author’s e-mail address immediately upon submission and the submission status will appear on the IDCMR congress website. If you do not receive the confirmation e-mail, please do not submit the abstract again, instead please contact the presentation chair at the following email: [email protected] or [email protected].

SUBMISSION GUIDELINES

Abstracts can only be submitted electronically through the IDCMR congress website.
You are allowed to be the presenting author of more than one abstract.
You are allowed to be a co-author of more than one abstract.
You must receive the approval of all co-authors before putting their names on the abstract.
Submission of similar abstracts from the same group is discouraged.
Scientific program committee reserve the right to reclassify submitted abstracts into the most appropriate area of review.
Abstracts will only be considered for presentation if they are not published or submitted for presentation elsewhere.

ABSTRACT LANGUAGE AND LENGTH
Abstracts and presentations must be written in English. Use Times New Roman typeface (12 point regular) throughout. The maximum length allowed for an abstract is approximately 250 words including blank spaces. The abstract title, the author(s) or names of institutions are not included in the count of 250 words. Abstract titles are limited to 15 words or less and should be entered in a title case format. In general, you should capitalize the first letter of each word unless it is a preposition or articles. Each authors (first name and last name) plus institution or affiliation should be listed in the proper order. One person must be identified as the presenting author by using the star (*).

ABSTRACT STRUCTURE AND CONTENT
In order to make the abstract as informative as possible, please include a brief statement of the objective of the study and/or the underlying hypotheses, the method used, the results observed, and the conclusions based upon the results. It is inadequate to state “The results will be discussed” or “The data will be presented”. You should subtitle the paragraphs in the following order: Introduction, Objectives, Methods, Results, and Conclusion.

The abstract text should be printed in sentence case. Trade names should not be presented in abstract. References, credits or the authors’ academic degrees or grant support are not to be included in the abstract body. Standard abbreviations may be employed in the text. Place special or unusual abbreviations in parentheses after the full wording at the first time it appears in the body of the text. Company names are not allowed in the title but can be named in the authors’ affiliation.

Consent for publication of individual patient data - applies to abstracts with identifiable patient information

For the publication of an abstract that contains identifiable information about patients, it is necessary that patients have given consent for the research to be published. For all abstracts that include identifiable patient details (e.g. gender, age, illness, location) or images, written informed consent for the publication of these must be obtained from the patient (or their parent or legal guardian).

It is the author’s responsibility to obtain written informed consent for publication of clinical details and/or clinical images from the patient/parent/guardian/relative of the patient. A respective statement needs to be included in the abstract text.

SCIENTIFIC GROUPS All abstracts must be submitted to an appropriate scientific group category for review based on the scientific content of the abstract. For the IDCMR congress, three submission categories are listed below:

Basic science research
Clinical research
Epidemiological research

DUPLICATION OF PUBLICATIONS
IDCMR does not accept re-submissions; abstracts must correspond to original, previously unpublished work. By submitting an abstract, the author confirms that the abstract was not presented/published at another meeting, and that the full paper was neither submitted not published.

DECLARATION OF CONFLICT OF INTEREST
IDCMR is committed to ensuring the integrity of its scientific, educational, and research programs. Abstract submission requires disclosure of any financial or other interest that might be construed as resulting in an actual, potential, or apparent conflict. The submitter is responsible for obtaining disclosure information from all co-authors, to be entered in the author section of the submission page.

PRESENTATION FORMATS AND ABSTRACT TOPICS
Accepted abstracts selected by expert reviewers will be presented in any of the following sessions: Oral Presentation Sessions, Poster Presentation Sessions. Authors are allowed to indicate their choice of preferred type of presentation in the provided space. In addition, authors should indicate if they are interested to participate in the competition. Please note that the final decisions regarding the allocation and the type of presentation of the submitted abstract will be made by the scientific program committee. It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author as no editing will be done by IDCMR.

ABSTRACT PRESENTATIONS
The accepted abstracts will be presented in two formats: Oral Abstract Sessions and Poster Discussion Sessions. All presenting authors will receive detailed guidelines as soon as their abstract has been accepted.

ORAL PRESENTATION SESSION
The Oral Presentation Sessions (OPS) consist of presentations of 10 minutes each and each followed by four minutes for discussion. The sessions are introduced by a session chair. As presenter you are required to prepare a PowerPoint presentation featuring the main findings of your work and all presentations must be uploaded to the main laptop of the IDCMR congress before the assigned oral presentation session. All oral presentations are subjected to the Oral Presentation Competition.

POSTER PRESENTATION SESSION
The Poster Presentation Session (PPS) will take place in the designated areas where you will present your work in a poster form. Each poster will be allocated a standard board. The physical dimensions of the standard poster display board will be 100 cm wide and 250 cm high, being presented in a vertical position. It is advised that actual usage area of the poster display board must be about 80 x 120 cm , leaving the lower area of the board approximately 50 cm from the floor unused.

Your reference code number will be marked on the board for setting up your poster. A poster should be self‐explanatory, clear and specific, and presents the material logically and legible. The title should be completed in a line and on the top of the poster, followed by the author(s) and affiliation. Illustrations, charts, graphs and photographs used may be similar to those used in making slides, although the lettering should be large and easy to read, approximately 1.0 cm high .

NOTIFICATION OF ACCEPTANCE
Notifications of acceptance or rejection of the abstracts from the regular submission will be emailed on or about August 15, 2025.

With the notification of acceptance, abstract presenters will be informed about the time and date of their presentation, and are asked to reconfirm their attendance. IDCMR cannot guarantee that presenting authors who do not show up to present their abstract during the session will be accepted for abstract presentations at future IDCMR congress

REGISTRATION AND PUBLICATION OF ABSTRACTS
The presenting author of an abstract must register for the IDCMR congress by August 21, 2025 for early registration deadline and September 24, 2025 for regular registration deadline. The registration fee will not be refunded if the abstract is rejected. Accepted abstracts will be published on the Conference Abstract Book.

WITHDRAWAL OF ABSTRACTS
You may withdraw your abstract at any time until July 15, 2025 by sending a request to IDCMR chair at the following email: [email protected] Failure to follow the above procedure may result in not being allowed to present at a future IDCMR meeting.

ASSISTANCE AND CONTACT
For any assistance for the submission of the abstract please contact the IDCMR conference web administrator: [email protected]

IDCMR Proceedings Series– Instructions for Authors Title (15 words or less)
A.B. Firstauthor¹, C. Coauthor² and D.E. Othercoauthor¹
¹ Institution/Department, Affiliation, City, Country
² Institution/Department, Affiliation, City, Country

Abstract — Instructions for preparing papers for the IDCMR proceedings series are presented. They are intended to guide the authors in preparing the electronic version of their paper. Only pa-pers prepared according to these instructions will be published in the paper and online version of the IDCMR proceedings. Provide an abstract of your paper no longer than 250 words.
Keywords — Enter up to five keywords and separate them by commas.

I. INTRODUCTION
These are the instructions for preparing papers for the IDCMR proceedings series. English is the official language. Please, do not forget to prove the spelling with your spell checker. Set the language to English (U.S.). Read the instructions in this sample paper carefully before typing.
The papers should be submitted in their final form. The publisher will perform no further adjustments. In the proceedings, the papers will be re- produced directly from the files submitted by the authors. The authors must upload their paper in MS Word and PDF format through the conference management system.
Detailed instructions for preparing the papers are listed in chapter II. WRITING THE PAPER.When you write the paper, you need to follow the rules.

II. WRITING THE PAPER
Paper Size: Select 21 x 27.9 cm (A4) paper. Only this paper size will be accepted.
Length: The maximum document size is seven pages. Abstracts only will not be published.
Margins: The page layout should be "mirror margins". Leave 1.25 inches margin at the top, 1.5 inches at the bottom, 1 inch at the left and right margin of the page.
Page layout: Type the paper in two columns 85.5 mm wide with a space of 6 mm between the columns. Each column should be left and right justified.
Fonts: Use Times New Roman typeface, standard size 12 point, and single line spacing throughout the paper.
Title: The title should be no longer than 15 words. Avoid unusual abbreviations. Center the title (12 point bold). Authors’ names and affiliations (Institution/Department, City, Country) shall span the entire page. Leave one blank line (10 point) after the title, one blank line (10 point) after the authors’ names and affiliations. Leave one blank line (20 point) between author’s info and the be-ginning of the paper.
Abstract: Provide an abstract of the paper (12 point regular), no longer than 250 words.
Style: Use separate sections for introduction, materials and methods, results, discussion, conclusions, acknowledgments (when appropriate), and references.
Headings: Enumerate Chapter Headings by Roman numbers (I., II., etc.). For Chapter Headings use ALLCAPS using font size 11 regular style. Leave one blank line (20 point) before and one blank line (10 point) after each Chapter Heading. Subchapter Headings are font 10, italic. Leave one blank line (15 point) before and one blank line (7,5 point) after each Subchapter Heading.
Body text: Use Times New Roman typeface (12 point regular) throughout. Only if you want to emphasize special parts of the text use Italics. Start a new paragraph by indenting it from the left margin by 4 mm (and not by inserting a blank line). Font sizes and styles to be used in the paper are summarized in Table 1.
Tables: Insert tables where appropriate (as close as possible to where they are mentioned in the text). Prefer positioning them at the top or at the bottom of the column. If necessary, span them over both columns. Enumerate them consecu- tively using Arabic numbers and provide a caption for each table (e.g. Table 1, Table 2,..). Use font 10 regular for Table caption and font 8 regular for the rest of table caption and table legend. Place table captions and table legend above the table. Leave one blank line before (15 point) and one after (5 point) the captions. Please keep in mind the distinction between tables and figures: tables only contain alphanumerical characters and no graphical elements.

Table 1 Font sizes and styles

Item	Font Size	Font Style
Title	12	Bold
Author	10	Regular
Authors’ info	10	Regular
Abstract	10	Regular
Keywords	10	Bold
Body text	10	Regular
Chapter heading	11	Regular
Subchapter heading	10	Italic
Table caption	10	Regular
Table legend	8	Regular
Column titles	8	Regular
Table data	8	Regular
Figure caption	10	Regular
Figure legend	8	Regular
Acknowledgment	10	Regular
References	10	Regular
Author’s address	8	Regular

Figures: Insert figures (max 3) where appropriate (as close as possible to where they are mentioned in the text). Prefer positioning them at the top or at the bottom of the column. If necessary, span them over both columns. Enumerate them consecutively using Arabic numbers and provide a caption for each figure (e.g. Fig. 1, Fig. 2,..). Use font 10 regular for Figure caption and font 8 regular for the rest of figure caption and figure legend. Place figure legend beneath figures. Leave one blank line before (5 point) and one after (15 point) the captions. Please keep in mind the distinction between tables and figures: tables only contain alphanumerical characters and no graphical elements. Do not use characters smaller than 8 points within figures. Figures are going to be re-produced in color in the electronic versions of the Proceedings, but when choosing graph colors, keep in mind that they might be printed in black and white color. Figure 1 is intended to illustrate the positioning of a figure and shows the logo of the IDCMR.

Fig. 1 IDCMR logo

Table 2 Table caption

Table legend

Table data

Equations: For inserting equations, use the Equation Editor. Enumerate the equations using Arabic numbers in brackets on the right hand side of the equation.
Itemizing: In case you need to itemize parts of your text, use either bullets or numbers, as shown below:

First item
Second item

Numbered first item
Numbered second item

References: Use Arabic numbers in square brackets to number references in such order as they appear in the text. List them in numerical or-der as presented under the heading ‘REFERENCES’ at the end of this Instructions.

III. COMPLIANCE WITH ETHICAL REQUIREMENTS
Conflict of interest
When an author or the institution of the author has a relationship, financial or otherwise, with individuals or organizations that could influence the author’s work inappropriately, a conflict of interest may exist. Examples of potential conflicts of interest may include but are not limited to academic, personal, or political relationships; employment; consultancies or honoraria; and finical connections such as stock ownership and funding. Although an author may not feel that there are conflicts, disclosure of relationships and interests that could be viewed by others as conflicts of interest affords a more transparent and prudent process. All authors must disclose any actual or potential conflict of interest. The proceedings will publish such disclosures if judged to be important to readers.

Statement of informed consent
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in writ- ten descriptions, photographs, and pedigrees un- less the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. In- formed consent for this purpose requires that a patient who is identifiable be shown the manu-script to be published. Authors should identify individuals who provide writing assistance and dis-close the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Statement of human and animal rights
When reporting experiments on human sub-jects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975,
as revised in 2000 and 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

IV. CONCLUSIONS
Submit your proceeding at IDCMR online submission website. Papers must be uploaded before the deadline (July 15, 2025). After a paper is accepted for oral or poster presentation, one of the authors must complete a registration form and pay the appropriate fees before the paper can be published in the Proceedings. Please pay attention to the registration deadline.

ACKNOWLEDGMENT
Format the Acknowledgment and References headlines without numbering.

CONFLICT OF INTEREST
Every paper must contain a declaration of conflicts of interest. If there are no such conflicts write “The authors declare that they have no conflict of interest”.

REFERENCES
The list of References should only include papers that are cited in the text and that have been published or accepted for publication. Citations in the text should be identified by numbers in square brackets and the list of references at the end of the paper should be numbered according to the order of appearance in the text. Examples of citations for Journal articles [1], books [2], the Digital Object Identifier (DOI) of the cited literature (which should be added at the end of the reference in question if available) [3], Proceedings papers [4] and electronic publications [5].
Cited papers that have been accepted for publication should be included in the list of references with the name of the journal and marked as ‘‘in press’’. The author is responsible for the accuracy of the references. Journal titles should be abbreviated according to Engineering Index Inc. References with correct punctuation.

Smith J, Jones M Jr, Houghton L et al. (1999) Future of health insurance. N Engl J Med 965:325–329
South J, Blass B (2001) The future of modern genomics. Blackwell, London
Smith J, Jones M Jr, Houghton L et al (1999) Future of health insurance. N Engl J Med 965:325–329 DOI 10.10007/s002149800025
Lock I, Jerov M, Scovith S (2003) Future of modeling and simulation, IFMBE Proc. vol. 4,World Congress on Med. Phys. & Biomed.Eng., Sydney, Australia, 2003, pp 789–792
IFMBE at http://www.ifmbe.org

Enter the information of the corresponding author:
Author:
Institute:
Address:
City:
Country:
Email:

Full Paper Submission Guidelines
On behalf of Prince of Songkla University Faculty of Dentistry and the IDCMR Secretariat Office welcome the submission of original contributions for oral and poster presentations at the IDCMR congress.

DEADLINE: JULY 15, 2025
Manuscripts received after this date will not be considered.

INSTRUCTIONS TO AUTHORS
Carefully read the guidelines below before submitting a manuscript. Acknowledgement of the receipt of your submission will be sent to the corresponding author’s e-mail address immediately upon submission and the submission status will appear on the IDCMR congress website. If you do not receive the confirmation e-mail, please do not submit the abstract again, instead please contact the IDCMR chair at the following email: [email protected] or [email protected]

SUBMISSION GUIDELINES

A manuscript must be written in English, use font of Times New Roman in a standard A4 paper (21.2 x 29.7 cm) with 2.5 cm margin on all four sides. The manuscript should be typewritten with double- spacing.
Numbers of page must be on the top right corner. The length of article should not exceed 10 pages of the journal
Measurement units such as length, height, weight, capacity etc. should be in metric units. Temperature should be in degree Celsius. Pressure units should be in mmHg. The hematologic measurement and clinical chemistry should follow International System Units or SI.
Standard abbreviation must be used for abbreviation and symbols .The abbreviation should not be used in the title and abstract. Full words of the abbreviation should be referred at the end of the first abbreviation in the content except the standard measurement units.
Position of the teeth may use full proper name such as maxillary right canine or symbols according to FDI two-digit notation and write full name in the parenthesis after the first mention such as tooth 31 (mandibular left central incisor).
Every illustration including tables must be referred in the articles. The contents and alphabets in the illustrations and tables must be in English. Numbers are used in Arabic form and limited asnecessary. Once the manuscript is accepted, an author may be requested to resubmit the high quality photos.

Please see the following template of a manuscript for JHSMR

Please study the guide for author and the information below before using this template Information for using this template

Please fill in the metadata of your paper in this template.
Please delete the explanation in green highlighting before submitting.
Please separate your complete manuscript into two files: Part 1 (title page) and Part 2 (Manuscript) before submitting.
Please prepare figures and tables that appear in your manuscript in a separate file.
1. The size of the figure should be 5x7 itches or 12.7x17.8 cm with at least 300 dpi in .jpg, .tiff, or .gif.
2. The total of figures + tables is no more than 8.

*** When you upload files in submission process with the JHSMR’s e-journal.
Please use the part 1 in a title page designation and the part 2 in a main document designation ***

(The manuscript and title page must be submitted as a Microsoft Word file.)

Part1: Title Page

Title: AAAAAAAAAAAAAAAAAAAAAAA

(The words which are compounded to the title should be used the capital letter in the first letter and next following a small letter of each word excepted preposition words. e.g. Cutaneous Manifestations in Chikungunya Disease)
First Name Surname, Degree^1*, First Name Surname, Degree¹, First Name Surname, Degree² , First Name Surname, Degree^1,2
¹Department, Faculty, University, City, State Zip code, Country.
²Department, Faculty, University, City, State Zip code, Country.

*Corresponding Author
Contact:First Name Surname
Affiliation: Department, Faculty, University, City, State Zip code, Country.
E-mail: AAAAAAAA
ORCID iD: AAAAAAAAA (for Researchers and Academic Staff at Prince of Songkla University)

(*corresponding author doesn’t fix in the first author, therefore it can move to another)

*Co-Author: First Name Surname
E-mail: AAAAAAAA
ORCID iD: AAAAAAAAA (for Researchers and Academic Staff at Prince of Songkla University)
*Co-Author: First Name Surname
E-mail: AAAAAAAA
ORCID iD: AAAAAAAAA (for Researchers and Academic Staff at Prince of Songkla University)
Running Title: BBBBBBBBBBB (this part will appear on the running head) (no more than 40 letters)
Keywords: word 1, word 2, word 3 (the keywords should be listed 3-5 keywords of the highlighting point of your paper, and ordered from a-z e.g.: isoflavonces, soy milk, Thailand)

Part 2: Text

Abstract Submission

SUBMISSION INFORMATION

TIMELINE FOR ABSTRACT SUBMISSION

SUBMISSION GUIDELINES/FORMATTING